BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16967353)

  • 1. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspirin resistance].
    Yilmaz MB; Balbay Y; Korkmaz S
    Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
    Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
    Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 18. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of aspirin in patients with cerebrovascular disease.
    Alberts MJ; Bergman DL; Molner E; Jovanovic BD; Ushiwata I; Teruya J
    Stroke; 2004 Jan; 35(1):175-8. PubMed ID: 14671242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.